High-risk Melanoma
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma (NCT06488482) | Uppsala University | 2024-12-19 |
| A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma (NCT01996202) | Duke University | 2013-11-01 |
| Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma (NCT00273910) | National Cancer Institute (NCI) | 2006-01-01 |
Track High-risk Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.